A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants
Running, not enrolling · Phase 1/Phase 2
Conditions studied: Active Noninfectious Uveitis Affecting the Posterior Segment
In brief
This study is researching an experimental drug called REGN7041 (also referred to as "study drug"). The study is focused on patients who have active inflammation inside of the eye without any signs of infection. The aim of the study is to see how safe and tolerable the study drug is. This is the first time the study drug is being tested in humans. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood and the fluid in the eye at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)
Key facts
- Study ID
- NCT07218770
- Run by
- Regeneron Pharmaceuticals
- People needed
- 72
- Starts
- 2025-12-17
- Expected to finish
- 2028-06-28
- Last updated by the study team
- 2026-04-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Retinal Consultants - Sacramento — Sacramento, California, United States
- Illinois Retina Associates — Oak Park, Illinois, United States
- Tennessee Retina — Nashville, Tennessee, United States
- Retina Consultants of Texas - Houston — Bellaire, Texas, United States
- Retina Consultants of Texas — Katy, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.